Physician

Wesley Scott Hilger, MD

According to 2025 Medicare claims, Wesley Hilger, MD (NPI: 1144205634) practices unknown physician specialty in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is UROGYNECOLOGY CONSULTANTS MEDICAL CORPORATION (NPI: 1750323119; TIN: 204937410) and primary practice location at 95661-2865.

Hilger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,075 traditional Medicare patients, billed 20,176 HCPCS/CPT codes, and received $689,101 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,760 prescription claims across 640 beneficiaries totaling $340,068 in drug costs, led by Gemtesa (Vibegron). DME data shows 103 claims. Open Payments data shows 9 records totaling $184. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $325,929 to $689,101. Similarly, Part D prescription costs have risen steadily, from $83,368 to $340,068. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$345K$689K2015 Medicare payment: $325,929 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $311,505 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $320,833 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $331,319 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $302,213 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $313,880 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $491,218 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $510,354 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $655,143 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $689,101 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155105,142$325,929
20164204,572$311,505
20174716,595$320,833
20185098,567$331,319
20194627,476$302,213
20205248,929$313,880
202172214,576$491,218
202278416,236$510,354
202391020,202$655,143
20241,07520,176$689,101

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$170K$340K2015 Drug cost: $83,368 (USD; Tot_Drug_Cst)2016 Drug cost: $142,510 (USD; Tot_Drug_Cst)2017 Drug cost: $222,550 (USD; Tot_Drug_Cst)2018 Drug cost: $218,039 (USD; Tot_Drug_Cst)2019 Drug cost: $275,188 (USD; Tot_Drug_Cst)2020 Drug cost: $258,429 (USD; Tot_Drug_Cst)2021 Drug cost: $287,497 (USD; Tot_Drug_Cst)2022 Drug cost: $267,921 (USD; Tot_Drug_Cst)2023 Drug cost: $291,119 (USD; Tot_Drug_Cst)2024 Drug cost: $340,068 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015250668$83,368
20163011,061$142,510
20173011,116$222,550
20183061,203$218,039
20193491,411$275,188
20203211,255$258,429
20214501,449$287,497
20224331,315$267,921
20235221,510$291,119
20246401,760$340,068

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$22K$44K2015 Medicare payment: $11,072 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $19,970 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $20,797 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $15,859 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $15,253 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $11,180 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $29,201 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $39,419 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $39,238 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $43,871 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151155$11,072
20161681$19,970
20171777$20,797
20181773$15,859
20191466$15,253
2020N/R41$11,180
20211987$29,201
202217104$39,419
20231795$39,238
202419103$43,871

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more257257$120
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more331365$98
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more609921$58
51701Insertion of temporary bladder tube376441$35
81002Urinalysis, manual test5191,109$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GemtesaVibegron32411,890$186,190
MyrbetriqMirabegron1226,750$96,995
EstradiolEstradiol23822,529$17,530
BotoxOnabotulinumtoxina11990$8,616
TrimethoprimTrimethoprim1204,226$4,762

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachN19103$43,871

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$184ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wesley Scott Hilger, MD?

Tedicare shows public-source Medicare data for Wesley Scott Hilger, MD (NPI 1144205634), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wesley Scott Hilger, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Wesley Scott Hilger, MD?

Wesley Scott Hilger, MD is linked to UROGYNECOLOGY CONSULTANTS MEDICAL CORPORATION (billing NPI 1750323119) in the available physician profile data.

Does Wesley Scott Hilger, MD have Open Payments data?

Wesley Scott Hilger, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.